Why the study?
Does preexisting antibody to Norwalk virus protect against illness upon re-exposure?
Does preexisting antibody to Norwalk virus protect against illness upon re-exposure?
Preexisting antibodies to Norwalk virus do not appear to confer immunity and may paradoxically be associated with higher susceptibility to illness upon re-exposure.
This is the authors' abstract. We don't add key points for this paper.
A solid-phase microtiter radioimmunoassay was established for the detection of Norwalk virus and its antibody, with clinical materials from human volunteers previously studied in Massachusetts as reagents. A study of 308 Massachusetts residents showed that serum antibody to Norwalk agent was rarely present during childhood but was detectable in approximately 50% of adults. All volunteers inoculated with Norwalk virus who developed illness seroconverted (10/10), whereas only one-third (5/15) of nonill volunteers seroconverted (P = 0.0009). The 10 nonill, nonseroconverting subjects had undetectable to low preexisting antibody levels. Paradoxically, 10/13 subjects with preexisting antibody became ill, whereas 17/25 lacking antibody did not (P = 0.009). All 3 subjects with preexisting anti-Norwalk radioimmunoassay blocking activity in duodenal intraluminal fluids became ill, whereas only 5/11 lacking such activity developed illness (P = 0.15). These data further support the unique concept that some individuals are susceptible to repeated infections with this agent, whereas others are incapable of developing infection.
Answers are grounded in this paper and cite their sources.
Preexisting Norwalk antibody may not protect and could mark higher susceptibility; leaves open humoral immunity's role and needs prospective confirmation.
No takes yet. Share an insight, caveat, or question.
Blacklow et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: